Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A25022 IPKine™ HRP, Mouse Anti-Rabbit IgG LCS An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer(A25022-7.3) 7.3 Cancer Cell 
KTA1020 Cell Counting Kit-8 (CCK-8) An Integrated Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation Study to Investigate the Potential …(KTA1020-3) 3 Biological Trace Element Research
KTB1030 CheKine™ Micro Superoxide Dismutases (SOD) Activity Assay Kit An investigation into the protective effects of various doses of boric acid on liver, kidney, and brain tissue damage caused by high levels of acute alcohol consumption(KTB1030-3.6) 3.6 International journal of Nanomedicine
KTB1040 CheKine™ Micro Catalase (CAT) Activity Assay Kit An investigation into the protective effects of various doses of boric acid on liver, kidney, and brain tissue damage caused by high levels of acute alcohol consumption(KTB1040-3.6) 3.6 Advanced Materials
KTB1640 CheKine™ Micro Glutathione Peroxidase (GSH-Px) Activity Assay Kit An investigation into the protective effects of various doses of boric acid on liver, kidney, and brain tissue damage caused by high levels of acute alcohol consumption(KTB1640-3.6) 3.6 Front. Pharmacol
A21120 AP, Goat Anti-Rabbit IgG An investigative study on the impact of DLK1 and NCoR1 knockdown by siRNA transfection on endometrial cancer proliferation: unveiling notch interactions.(A21120-3.5) 3.5 Medical Oncology 
A21020 HRP, Goat Anti-Rabbit IgG An m6A methyltransferase confers host resistance by degrading viral proteins through ubiquitination(A21020-15.7) 15.7 Journal of Endodontics
A21010 HRP, Goat Anti-Mouse IgG An m6A methyltransferase confers host resistance by degrading viral proteins through ubiquitination.(A21010-15.7) 15.7 Nature Communications 
BMU102-CN An oncolytic virus–T cell chimera for cancer immunotherapy(BMU102-CN-41.7) 41.7
BMU102 An oncolytic virus–T cell chimera for cancer immunotherapy.(BMU102-33) 33 Nature Biotechnology